Mangalam Drugs & Organics Share Price Targets
Mangalam Drugs & Organics Limited | |||
 | Price: ₹74.30 (-0.21%) | ||
| 52 Week Low: ₹70.10 52 Week High: ₹140.50 | |||
| Market Capital: 164.48 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Mangalam Drugs & Organics Stock Comparison: Mangalam Drugs & Organics vs Krebs Biochemicals & | Mangalam Drugs & Organics vs Bafna Pharmaceuticals | Mangalam Drugs & Organics vs Bal Pharma | Mangalam Drugs & Organics vs Vaishali Pharma | Mangalam Drugs & Organics vs AAREYDRUGS | Mangalam Drugs & Organics vs LOTUSEYE | |||
Show Table of Contents
Table of Contents
Mangalam Drugs & Organics Recent Performance
Over the past 446 trading days, the value of Mangalam Drugs & Organics's stock has lost ₹27.05 (-26.69%). On 07 Nov 2023, one share was worth ₹101.35 and by 29 Aug 2025, the value dropped to ₹74.30. During this period it created a highest high of ₹144.99 and lowest low of ₹70.10.
Mangalam Drugs & Organics Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 79.84 (+7.45%) | Price Action: 11 Aug 2025 High |
| Tomorrow Target 2 | 79 (+6.32%) | Price Action: 11 Apr 2025 High |
| Tomorrow Target 1 | 78.05 (+5.04%) | Price Action: 20 Jun 2025 Low |
| Current Price | 74.30 | Mangalam Drugs & Organics's share price as of 29 Aug 2025 |
| Stop Loss 1 | 70.1 (-5.66%) | Price Action: May 2025 Low |
| Stop Loss 2 | 69.4 (-6.6%) | Price Action: Chart |
| Stop Loss 3 | 68.15 (-8.27%) | Price Action: Chart |
Summary
29 Aug 2025: Mangalam Drugs & Organics finished the day at ₹74.30, losing ₹-0.16 (-0.21%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -8.28% to 7.46% with:
- Target prices: ₹78.05 to ₹79.84
- Support levels: ₹70.1 to ₹68.15
- Recent high: ₹76.49
- Recent low: ₹73.68
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Mangalam Drugs & Organics Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 78.8 (+6.05%) | Price Action: 30 May 2025 Low |
| Next Week Target 2 | 77.81 (+4.72%) | Price Action: 29 Apr 2025 Low |
| Next Week Target 1 | 76.86 (+3.44%) | Fibonacci Extension Level 23.60% |
| Current Price | 74.30 | Mangalam Drugs & Organics's share price as of 29 Aug 2025 |
| Stop Loss 1 | 73.51 (-1.07%) | Fibonacci Retracement Level 98.60% |
| Stop Loss 2 | 72.6 (-2.29%) | Price Action: Aug 2025 Low |
| Stop Loss 3 | 71.6 (-3.64%) | Price Action: 08 May 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -3.63% to 6.06% with:
- Upper targets: ₹76.86 to ₹78.8
- Support levels: ₹73.51 to ₹71.6
Mangalam Drugs & Organics Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 80.69 (+8.6%) | Price Action: 18 Aug 2025 Low |
| Next Month Target 2 | 79.89 (+7.52%) | Price Action: 08 Aug 2025 High |
| Next Month Target 1 | 79.05 (+6.39%) | Price Action: 16 Apr 2025 Low |
| Current Price | 74.30 | Mangalam Drugs & Organics's share price as of 29 Aug 2025 |
| Stop Loss 1 | 73 (-1.75%) | Price Action: 06 May 2025 Low |
| Stop Loss 2 | 72.01 (-3.09%) | Price Action: Apr 2025 Low |
| Stop Loss 3 | 71.26 (-4.09%) | Price Action: 07 May 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -4.09% to 8.60% with:
- Target range: ₹79.05 to ₹80.69
- Support levels: ₹73 to ₹71.26
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
